Related Experiment Video
Updated: Feb 9, 2026

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
Published on: June 6, 2025
Insights
A 10-year clinical trial found that low-dose maintenance chemotherapy improves survival for children with high-risk rhabdomyosarcoma. This new approach is now the standard of care in the EU.
Area of Science:
- Pediatric Oncology
- Clinical Trials
- Cancer Chemotherapy
Background:
- High-risk rhabdomyosarcoma presents a significant challenge in pediatric oncology.
- Standard treatment protocols require optimization to improve patient outcomes.
Abstract:
Findings from a 10-year clinical trial show improved survival rates among children with high-risk rhabdomyosarcoma who receive low-dose maintenance chemotherapy following standard treatment. The results have established a new standard of care for this disease in the EU.
Related Concept Videos
RMS Value in AC Circuit
Mathematically, the RMS value of an AC waveform is the square root...
Maintenance of the ES Cell State
Self-Evaluation Maintenance Model
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

